Tekes Venture Capital
VC Fund
Tekes Venture Capital is a VC fund focused on Genetics and Hospital. Tekes Venture Capital invests in companies in their early stages of development. Its purpose is to develop Finland's venture capital market.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Tekes Venture Capital invests in
Stages Tekes Venture Capital invests in
Countries Tekes Venture Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Genetics 1 (50%)
- Hospital 1 (50%)
- Analytics 1 (50%)
- Health Care 1 (50%)
- Biotechnology 1 (50%)
Stage
- Seed 1 (50%)
- Venture - Series Unknown 1 (50%)
Country
- Finland 1 (50%)
- United States 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Esko Raunio
Managing Director
|
Managing Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| 720° is a cloud based analytics solution for indoor environmental quality monitoring. They believe that health and satisfaction at work is everyone’s prerogative. Their passion is to improve people’s lives and allow organisations and building owners to offer the best working environments achievable. | $3.3M / Seed / Jan 31, 2019 | ||
| Blueprint Genetics provides genetic diagnostics of rare diseases based on Next-Generation Sequencing (NGS).The professional genetic tests are targeted for hospitals and research groups. Blueprint Genetics aims to disrupt the market by decreasing the price level of genetic diagnostics significantly while increasing quality and adding clinicalinsight to the results statements.The tests are based on a novel NGS method called OS-Seq:tm: that was developed in the Stanford University.The product roadmap of the company covers a long list of diagnostics for different hereditary diseases. The currently available products cover relevant rare hereditary cardiovascular diseases, such as cardiomyopathies, arrhythmias and aorta diseases.The company is based in Helsinki, Finland and has an office also in Los Angeles, CA. | $3.9M / Venture - Series Unknown / Sep 01, 2014 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Tekes Venture Capital invest in?
Tekes Venture Capital invests primarily in Genetics, Hospital and Analytics startups, most often at Seed and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in Finland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Tekes Venture Capital?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Tekes Venture Capital?
The team at Tekes Venture Capital includes Esko Raunio (Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
